Why it is vital that the roll out of hybrid closed-loop tech is funded
With the NICE appraisal of who in England and Wales should have access to hybrid closed-loop technology set to conclude by the end of the
With the NICE appraisal of who in England and Wales should have access to hybrid closed-loop technology set to conclude by the end of the
Many people with diabetes experience diabetes distress, anxiety, or depression. In turn, depression is linked to chronic conditions like diabetes, high blood pressure, heart disease, arthritis,
People taking semaglutide or liraglutide for weight management are at a higher risk of rare but potentially serious gastrointestinal issues, compared with those taking naltrexone/bupropion,
Diabetes research funding organisation JDRF has announced the appointment of two new Board Directors, Nadia Swann and Sarah Johnson. Johnson is currently Head of Patient
The Royal College of Physicians (RCP) has announced the imminent launch of a programme to improve and standardise diabetes care in hospitals across the UK.
Glooko has launched a sleek new Glooko Mobile App in order to make it easier for users with diabetes to navigate, to organize their data
The National Institute for Health and Clinical Excellence (NICE) has recommended tirzepatide (Mounjaro, produced by Eli Lilly) as a new treatment option for some people
A recent research review has concluded that Type 1 diabetes has a significant negative effect on the growth of children. The review found evidence of
Adults with Type 1 diabetes may have transient increases in glucose levels in the days after receiving a Covid-19 vaccine booster, according to a study
The NHS is expanding blood pressure checks available in local communities –including barbershops, mosques and at a dominoes club – as part of a major